Sign in
HCM Stock Price, Chart, Stats & News
HUTCHMED (China) Limited
Save
1.77B
Market cap
3.83x
Current P/E
11.47x
Forward P/E
HCM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 8.93% |
Operating margin | -3.27% |
Pretax margin | 88.85% |
Net margin | 77.53% |
Effective tax rate | 12.61% |
ROA | 26.63% |
ROE | 41.91% |
D/E | 0.08x |
Interest coverage ratio | – |
HCM valuation
P/E | 3.83x |
P/S | 4.14x |
P/B | 1.95x |
P/CF | -74.21x |
P/FCF | -50.23x |
P/OCF | -74.21x |
PEG | 0.06x |
EV multiple | -329.44x |
About
HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally.
Similar securities
Based on sector and market capitalization
Report issue